Clinical trial
A Randomized Phase II Study Comparing Two Schedules of Hyperfractionated Thoracic Radiotherapy in Limited Disease Small Cell Lung Cancer
NCT02041845 is registered in ClinicalTrials.gov with Norwegian University of Science and Technology as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Randomized Phase II Study Comparing Two Schedules of Hyperfractionated Thoracic Radiotherapy in Limited Disease Small Cell Lung Cancer
- Lead sponsor
- Norwegian University of Science and Technology
- Phase
- Not applicable
- Overall status
- Active, not recruiting
- Start date
- July 8, 2014
- Completion date
- December 31, 2033
- Enrollment
- 177 (actual)
- Sites
- 22
Conditions
As the registry lists them; a condition with its own page is linked.